Skip to content
Recall Observatory FDA recall evidence

Device product

Atellica CH Enzymatic Creatinine (ECRE_2) reagent, SMN 11097533

Z-1231-2020

December 18, 2019

Class II

Product summary

Firm
Siemens Healthcare Diagnostics, Inc.
Event
Event 84612
Status
Terminated
Classification
Class II
Quantity
824 units
Official record key
device-enforcement:Z-1231-2020

Official wording

Reason: There is a potential for falsely depressed creatinine results for patients on phenindione therapy when using the enzymatic methodology. Interference has not been observed with the creatinine Jaffe methodology.

Code information: UDI Number: 00630414595795 Lots: All lots

Distribution pattern: US Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    There is a potential for falsely depressed creatinine results for patients on phenindione therapy when using the enzymatic methodology. Interference has not been observed with the creatinine Jaffe methodology.

Field note

Send feedback

We'll only use this to respond to your feedback.